Europe Blood and Blood Components Market Report Probes the 5 Billion Size, Share, Growth Report and Future Analysis by 2033

Europe Blood and Blood Components Market by By Component (Red Blood Cells (RBCs), Plasma, Platelets ), by By Application (Therapeutic Applications, Diagnostics ), by By End-User (Hospitals, Blood Banks, Diagnostic Centers), by Europe (Germany, France, United Kingdom, Italy, Spain, Netherlands, Sweden, Norway, Switzerland) Forecast 2025-2033

Europe Blood and Blood Components Market Report Probes the 5 Billion Size, Share, Growth Report and Future Analysis by 2033

Key Insights

The size of the Europe Blood and Blood Components Market market was valued at USD 5 Billion in 2023 and is projected to reach USD 4.76 Billion by 2032, with an expected CAGR of -0.7% during the forecast period. The Europe blood and blood components market is mainly about the collection, processing, storage, and distribution of critical blood components such as red blood cells, plasma, and platelets for therapeutic and medical interventions. Such components are utilized widely in surgeries, trauma care, cancer treatment, organ transplants, and the management of hematological disorders like anemia and clotting deficiencies. Plasma derivatives also support the production of immunoglobulins and clotting factors. However, there are challenges, including ensuring the safety and sufficiency of blood supply, prevention of transfusion-transmitted infections, and adherence to strict regulatory standards. There are also logistical issues in the management of storage and transportation as well as high costs of advanced collection and testing technologies. Fluctuating donor participation rates and wastage due to mismanagement further stress the system. These challenges notwithstanding, the market is buoyed by improvements in blood collection and processing technologies as well as increased awareness about healthcare. Some of the players who have invested in innovation and strategies on engagement of donors for the better availability and safety of blood supplies in Europe are Fresenius Kabi, Grifols S.A., CSL Behring, and Terumo Corporation.

Europe Blood and Blood Components Market Concentration & Characteristics

The Europe Blood and Blood Components Market is highly concentrated, with a few dominant players controlling a significant market share. These players include:

International Federation of Red Cross and Red Crescent Societies (IFRC)
American Association of Blood Banks (AABB)
Welsh Blood Services
NHS Blood and Transplant (NHSBT)

The market is characterized by innovation and technological advancements, with players investing in research and development to improve the safety, efficacy, and shelf life of blood components. Regulations play a crucial role in ensuring the quality and safety of blood components, with stringent guidelines governing blood collection, testing, and distribution.

Europe Blood and Blood Components Market Trends

Key market trends include:

Increasing demand for blood components in healthcare: The rising prevalence of chronic diseases, trauma, and surgeries has led to a growing demand for blood components.
Technological advancements in blood collection and processing: Automation and digitization have improved the efficiency and accuracy of blood collection, processing, and testing.
Rising patient awareness and education: Public health campaigns and educational initiatives have increased patient awareness of the importance of blood donation and the use of blood components in medical treatments.

Europe Blood and Blood Components Market Growth

Key Region or Country & Segment to Dominate the Market

Germany is the largest market for blood and blood components in Europe, due to its large population and healthcare expenditure.
France is another significant market, with a strong healthcare system and a growing emphasis on blood donation.
The hospital segment is expected to dominate the market, as hospitals account for a large share of demand for blood components.

Europe Blood and Blood Components Market Product Insights Report Coverage & Deliverables

The report covers various aspects of the Europe Blood and Blood Components Market, including:

Comprehensive analysis of the market size, share, and growth
In-depth analysis of market trends, drivers, and restraints
Detailed segmentation of the market based on type, end-user, and region
Identification of key market players and their competitive strategies
Future outlook and projections for the market

Europe Blood and Blood Components Market Analysis

The market is expected to witness moderate growth in the coming years, driven by the increasing demand for blood components in healthcare and technological advancements. However, factors such as competition from synthetic blood substitutes and the rising cost of blood collection and processing could influence market growth.

Europe Blood and Blood Components Market Regional Insights

The regional breakdown of the market is as follows:

Europe:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Netherlands
- Sweden
- Norway
- Switzerland

Driving Forces: What's Propelling the Europe Blood and Blood Components Market

Rising demand for blood components in healthcare
Technological advancements in blood collection and processing
Increasing patient awareness and education
Government initiatives promoting blood donation
Stringent regulations ensuring blood safety and quality

Challenges and Restraints in Europe Blood and Blood Components Market

Competition from synthetic blood substitutes
Rising cost of blood collection and processing
Limited availability of blood donors
Ethical concerns regarding blood transfusions

Emerging Trends in Europe Blood and Blood Components Market

Development of personalized blood components
Advances in tissue engineering and regenerative medicine
Telemedicine and remote blood collection
Use of artificial intelligence in blood component analysis
Blockchain technology for enhancing blood traceability

Europe Blood and Blood Components Industry News

October 2023: AABB announces new guidelines for the collection and storage of blood components.
November 2023: IFRC launches a campaign to raise awareness about the importance of blood donation.

Leading Players in the Europe Blood and Blood Components Market

Europe Blood and Blood Components Market Segmentation

By Component
- Red Blood Cells (RBCs)
- Plasma
- Platelets
By Application
- Therapeutic Applications (e.g., oncology, cardiovascular surgeries)
- Diagnostics (e.g., blood typing, disease diagnosis)
By End-User
- Hospitals
- Blood Banks
- Diagnostic Centers

Europe Blood and Blood Components Market Segmentation By Geography

1. Europe
- 1.1. Germany
- 1.2. France
- 1.3. United Kingdom
- 1.4. Italy
- 1.5. Spain
- 1.6. Netherlands
- 1.7. Sweden
- 1.8. Norway
- 1.9. Switzerland

Europe Blood and Blood Components Market Regional Share

Europe Blood and Blood Components Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2019-2033
Base Year	2024
Estimated Year	2025
Forecast Period	2025-2033
Historical Period	2019-2024
Growth Rate	CAGR of -0.7% from 2019-2033
Segmentation	By By Component Red Blood Cells (RBCs) Plasma Platelets By By Application Therapeutic Applications Diagnostics By By End-User Hospitals Blood Banks Diagnostic Centers By Geography Europe Germany France United Kingdom Italy Spain Netherlands Sweden Norway Switzerland

Table Of Content

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Rising demand for blood components in healthcare Technological advancements in blood collection and processing Increasing patient awareness and education Government initiatives promoting blood donation Stringent regulations ensuring blood safety and quality
- - 3.3. Market Restrains
  - - 3.3.1. Challenges and Restraints in Europe Blood and Blood Components Market Competition from synthetic blood substitutes Rising cost of blood collection and processing Limited availability of blood donors Ethical concerns regarding blood transfusions
- - 3.4. Market Trends
  - - 3.4.1. Development of personalized blood components Advances in tissue engineering and regenerative medicine Telemedicine and remote blood collection Use of artificial intelligence in blood component analysis Blockchain technology for enhancing blood traceability
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. Europe Blood and Blood Components Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by By Component
  - 5.1.1. Red Blood Cells (RBCs)
  - 5.1.2. Plasma
  - 5.1.3. Platelets
- 5.2. Market Analysis, Insights and Forecast - by By Application
  - 5.2.1. Therapeutic Applications
  - 5.2.2. Diagnostics
- 5.3. Market Analysis, Insights and Forecast - by By End-User
  - 5.3.1. Hospitals
  - 5.3.2. Blood Banks
  - 5.3.3. Diagnostic Centers
- 5.4. Market Analysis, Insights and Forecast - by Region
  - 5.4.1. Europe
6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- - 6.2. Company Profiles
  - - 6.2.1 International Federation of Red Cross and Red Crescent Societies (IFRC)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 American Association of Blood Banks (AABB)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Welsh Blood Services
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 NHS Blood and Transplant (NHSBT)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 Fresenius Kabi
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Grifols S.A.
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 CSL Behring
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Terumo Corporation
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 Sanquin Blood Supply Foundation
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)
    - 6.2.10 Biocryst Pharmaceuticals
      6.2.10.1. Overview
      6.2.10.2. Products
      6.2.10.3. SWOT Analysis
      6.2.10.4. Recent Developments
      6.2.10.5. Financials (Based on Availability)
    - 6.2.11 Baxter International Inc.
      6.2.11.1. Overview
      6.2.11.2. Products
      6.2.11.3. SWOT Analysis
      6.2.11.4. Recent Developments
      6.2.11.5. Financials (Based on Availability)
    - 6.2.12 Octapharma AG
      6.2.12.1. Overview
      6.2.12.2. Products
      6.2.12.3. SWOT Analysis
      6.2.12.4. Recent Developments
      6.2.12.5. Financials (Based on Availability)
    - 6.2.13 HemaCare Corporation
      6.2.13.1. Overview
      6.2.13.2. Products
      6.2.13.3. SWOT Analysis
      6.2.13.4. Recent Developments
      6.2.13.5. Financials (Based on Availability)
    - 6.2.14 BloodCenter of Wisconsin
      6.2.14.1. Overview
      6.2.14.2. Products
      6.2.14.3. SWOT Analysis
      6.2.14.4. Recent Developments
      6.2.14.5. Financials (Based on Availability)
    - 6.2.15 Abbott Laboratories
      6.2.15.1. Overview
      6.2.15.2. Products
      6.2.15.3. SWOT Analysis
      6.2.15.4. Recent Developments
      6.2.15.5. Financials (Based on Availability)

List of Figures

Figure 1: Europe Blood and Blood Components Market Revenue Breakdown (Billion, %) by Product 2024 & 2032
Figure 2: Europe Blood and Blood Components Market Share (%) by Company 2024

List of Tables

Table 1: Europe Blood and Blood Components Market Revenue Billion Forecast, by Region 2019 & 2032
Table 2: Europe Blood and Blood Components Market Volume k Units Forecast, by Region 2019 & 2032
Table 3: Europe Blood and Blood Components Market Revenue Billion Forecast, by By Component 2019 & 2032
Table 4: Europe Blood and Blood Components Market Volume k Units Forecast, by By Component 2019 & 2032
Table 5: Europe Blood and Blood Components Market Revenue Billion Forecast, by By Application 2019 & 2032
Table 6: Europe Blood and Blood Components Market Volume k Units Forecast, by By Application 2019 & 2032
Table 7: Europe Blood and Blood Components Market Revenue Billion Forecast, by By End-User 2019 & 2032
Table 8: Europe Blood and Blood Components Market Volume k Units Forecast, by By End-User 2019 & 2032
Table 9: Europe Blood and Blood Components Market Revenue Billion Forecast, by Region 2019 & 2032
Table 10: Europe Blood and Blood Components Market Volume k Units Forecast, by Region 2019 & 2032
Table 11: Europe Blood and Blood Components Market Revenue Billion Forecast, by By Component 2019 & 2032
Table 12: Europe Blood and Blood Components Market Volume k Units Forecast, by By Component 2019 & 2032
Table 13: Europe Blood and Blood Components Market Revenue Billion Forecast, by By Application 2019 & 2032
Table 14: Europe Blood and Blood Components Market Volume k Units Forecast, by By Application 2019 & 2032
Table 15: Europe Blood and Blood Components Market Revenue Billion Forecast, by By End-User 2019 & 2032
Table 16: Europe Blood and Blood Components Market Volume k Units Forecast, by By End-User 2019 & 2032
Table 17: Europe Blood and Blood Components Market Revenue Billion Forecast, by Country 2019 & 2032
Table 18: Europe Blood and Blood Components Market Volume k Units Forecast, by Country 2019 & 2032
Table 19: Germany Europe Blood and Blood Components Market Revenue (Billion) Forecast, by Application 2019 & 2032
Table 20: Germany Europe Blood and Blood Components Market Volume (k Units) Forecast, by Application 2019 & 2032
Table 21: France Europe Blood and Blood Components Market Revenue (Billion) Forecast, by Application 2019 & 2032
Table 22: France Europe Blood and Blood Components Market Volume (k Units) Forecast, by Application 2019 & 2032
Table 23: United Kingdom Europe Blood and Blood Components Market Revenue (Billion) Forecast, by Application 2019 & 2032
Table 24: United Kingdom Europe Blood and Blood Components Market Volume (k Units) Forecast, by Application 2019 & 2032
Table 25: Italy Europe Blood and Blood Components Market Revenue (Billion) Forecast, by Application 2019 & 2032
Table 26: Italy Europe Blood and Blood Components Market Volume (k Units) Forecast, by Application 2019 & 2032
Table 27: Spain Europe Blood and Blood Components Market Revenue (Billion) Forecast, by Application 2019 & 2032
Table 28: Spain Europe Blood and Blood Components Market Volume (k Units) Forecast, by Application 2019 & 2032
Table 29: Netherlands Europe Blood and Blood Components Market Revenue (Billion) Forecast, by Application 2019 & 2032
Table 30: Netherlands Europe Blood and Blood Components Market Volume (k Units) Forecast, by Application 2019 & 2032
Table 31: Sweden Europe Blood and Blood Components Market Revenue (Billion) Forecast, by Application 2019 & 2032
Table 32: Sweden Europe Blood and Blood Components Market Volume (k Units) Forecast, by Application 2019 & 2032
Table 33: Norway Europe Blood and Blood Components Market Revenue (Billion) Forecast, by Application 2019 & 2032
Table 34: Norway Europe Blood and Blood Components Market Volume (k Units) Forecast, by Application 2019 & 2032
Table 35: Switzerland Europe Blood and Blood Components Market Revenue (Billion) Forecast, by Application 2019 & 2032
Table 36: Switzerland Europe Blood and Blood Components Market Volume (k Units) Forecast, by Application 2019 & 2032

STEP 1 - Identification of Relevant Samples Size from Population Database

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.

Frequently Asked Questions

Get a Free Sample

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Pricing

Looking for a Custom Report?

We offer personalized report customization at no extra cost, including the option to purchase individual sections or country-specific reports. Plus, we provide special discounts for startups and universities. Get in touch with us today!

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Director of Business Development

Sarah L

The insights provided in this report were spot-on and exactly what we needed to guide our strategic planning. The level of detail on industry trends and forecasts is unmatched. It saved us countless hours and gave us a significant advantage!"

Europe Blood and Blood Components Market Report Probes the 5 Billion Size, Share, Growth Report and Future Analysis by 2033